For 70 years, antipsychotic medications have focused on the blockade of dopaminergic signaling at dopamine D2 receptors. This video describes recent advances in the understanding of another mechanism which may be able to modulate dopaminergic activity, as well as other neurotransmitters.
This website is specifically designed and contains information only intended for Medical Directors, Pharmacy Directors, Pharmacy and Therapeutics committee members, Quality Directors, Case Managers, Accountable Care Organizations, hospital or Integrated Delivery Network customers, and other population health team members. Please certify that you are one of the intended audiences by clicking the “Yes” button below to proceed.